Clinical Trial Update: Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of triple therapy with dulaglutide, SGLT2 inhibitors, and finerenone in Chinese adults with type 2 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dulaglutide (dulaglutide)
• Finerenone (finerenone)
• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: First Affiliated Hospital of Wannan Medical College | Conditions: T2DM (Type 2 Diabetes Mellitus), CKD - Chronic Kidney Disease | Phase 4 | Status: NOT_YET_RECRUITING